STONY BROOK, N.Y. - December 12, 2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it plans to release its fiscal 2022 fourth quarter and year-end financial results after the market close on Wednesday, December 14, 2022. The Company’s management will host a conference [...]
Almost exactly a year ago, the Congress with a unanimous vote passed the Uyghur Forced Labor Prevention Act (UFLPA). No partisan divide exists with the American people: they want forced labor out of their imported products, and are especially concerned by the human rights violations against the Muslim minorities of the Xinjiang Uyghur Autonomous Region of China, [...]
STONY BROOK, N.Y. – October 24, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today plans to establish a new, separate manufacturing facility to be located in Suffolk County, New York, for the enzymatic production of cGMP LinearDNA™ for use [...]
STONY BROOK, N.Y. – October 10, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today that it received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply agreement for the bulk manufacture of [...]
STONY BROOK, N.Y. – September 26, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the “Company”), a leader in polymerase chain reaction (PCR”)-based technologies, today announced the publication of a manuscript, co-authored with international academic and industry scientists, containing data demonstrating that a LinearDNA™-based vaccine candidate (the “vaccine candidate”) reduced [...]
STONY BROOK, N.Y. and ITHICA, N.Y. – September 8, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, and the Cornell University College of Veterinary Medicine (“CUCVM”) announced the signing of a research agreement (the “Agreement”) to advance LinearDNA™-based [...]
STONY BROOK, N.Y. – September 7, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference [...]
STONY BROOK, N.Y. – September 6, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (“ADCL”), has launched monkeypox testing as a clinical reference laboratory testing service available [...]
Outside the pox: After revolutionizing COVID testing, Applied DNA Sciences is getting out in front of the monkeypox virus. AUGUST 22, 2022 By GREGORY ZELLER // Applied DNA Sciences is ready to play a little monkey ball. The Stony Brook-based biotech – part supply-chain authenticator, part Polymerase Chain Reaction-based DNA technology leader, [...]